Products with Anti-diabetic bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN2338 | 1,2,3,4,6-O-Pentagalloylglucose |
| 1,2,3,4,6-O-Pentagalloylglucose(PGG) has antimutagenic, anti-proliferative, anti-invasive,vasodilatory, anti-inflammatory, anti-parasitic, anti-HBV, and antioxidant activities. PGG may serve as a model for the development of new types of anti-diabetic and anti-metabolic syndrome therapeutics. PGG dilates vascular smooth muscle and suppresses the vascular inflammatory process via endothelium-dependent nitric oxide (NO)/cGMP signaling; it also has inhibition of inducible NO synthase and cyclooxygenase-2 activity. | |
| BCN2465 | Soyasaponin Bd |
| Cinnamic aldehyde, a COX-2 inhibitor, exhibits cardioprotective, antidepressant-like, anti-leukemia, anti-oxidative and anti-inflammatory properties. Its supplementation can improve glucose and lipid homeostasis in diabetic animals. | |
| BCN2572 | Kalopanaxsaponin H |
| 1. Kalopanaxsaponin H has antidiabetic activity. | |
| BCN2640 | Cycloart-23-ene-3,25-diol |
| 1. Cycloart-23-ene-3,25-diol has anti-inflammatory activity . 2. Cycloart-23-ene-3,25-diol has protective activity against streptozotocin induced toxicity. 3. Cycloart-23-ene-3,25-diol treatment can decrease liver malondialdehyde but increase superoxidase dismutase and reduced glutathione. | |
| BCN2679 | Gymnemic acid I |
| 1. Gymnemic acids have been reported to effect a natural treatment for diabetes. 2. Gymnemic acids inhibit rabbit glyceraldehyde-3-phosphate dehydrogenase and induce a smearing of its electrophoretic band and dephosphorylation. | |
